Wound Closure Study in Carpal Tunnel and Trigger Finger Surgery

Absorbable Versus Non-Absorbable Suture in Carpal Tunnel and Trigger Finger Wound Closure

Status

Withdrawn

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03781141

Enrollment

Registered

2018-12-19

Start date

2019-12-01

Completion date

2026-03-01

Last updated

2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome, Trigger Finger

Brief summary

Does a difference in patient satisfaction and cosmetic outcome exist between wound closure with absorbable or non-absorbable sutures.

Detailed description

The study will involve randomizing patients to wound closure with absorbable or non-absorbable sutures. We will if scar formation (symptoms and aesthetics) if different between the two types of closures as determined by the patient and observer scar assessment scale version 2.0 (POSAS) and the patient-rated wrist/hand evaluation (PRWHE), between absorbable and non-absorbable suture for wound closure of open carpal tunnel release and trigger finger pulley release.

Interventions

PROCEDUREWound closure

Comparison of two wound closures

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Masking description

Blinded assessment for wound healing

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Any patient greater than or equal to 18 years of age. * Any patient undergoing primary open carpal tunnel release or primary trigger finger pulley release

Exclusion criteria

* Any patient identified outside of the proposed study time period. * Any patient receiving revision surgery * Patients who have had prior ipsilateral palmar or finger surgery * Patients with Dupuytren's disease

Design outcomes

Primary

Measure	Time frame	Description
Scar formation with the Patient and Observer Scare Assessment Scale	1 year	Blinded scar assessment utilizing the patient and observer scar assessment scale version 2.0 (POSAS). The POSAS is scored from the perspective of the patient and a blinded observer independently. Scores range from 1 to 10 with 1 indicating normal skin and 10 indicating the worst scar imaginable. The 1 to 10 scoring is performed in 6 domains of various scar characteristics to obtain a total score ranging from 10 to 60. Additionally, there is an overall scar appearance score that ranges from 1 to 10 with 1 indicating normal skin and 10 indicating the worst scar imaginable.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORPeter C Rhee

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026